Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory

American Journal of Psychiatry

Volumn 160, Issue 2, 2003, Pages 334-340

  Yasuno, Fumihiko ^b   Suhara, Tetsuya ^a   Nakayama, Takashi ^b   Ichimiya, Tetsuya ^b   Okubo, Yoshiro ^b   Takano, Akihiro ^b   Ando, Tomomichi ^b   Inoue, Makoto ^b   Maeda, Jun ^b   Suzuki, Kazutoshi ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; GROWTH HORMONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; TANDOSPIRONE; DIAGNOSTIC AGENT; PIPERAZINE DERIVATIVE; PLACEBO; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN RECEPTOR;

ARTICLE; BODY TEMPERATURE; BRAIN; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MEMORY; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; VERBAL MEMORY; ADULT; ATTENTION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; LEARNING; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; WECHSLER INTELLIGENCE SCALE;

ADULT; ATTENTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HIPPOCAMPUS; HUMANS; MALE; MEMORY; MIDDLE AGED; PIPERAZINES; PLACEBOS; PYRIDINES; PYRIMIDINES; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; TOMOGRAPHY, EMISSION-COMPUTED; VERBAL LEARNING; WECHSLER SCALES;

EID: 0037318247     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.2.334     Document Type: Article

References (49)

1. Winkler J, Suhr ST, Gage FH, Thal LJ, Fisher LJ: Essential role of neocortical acetylcholine in spatial memory. Nature 1995; 375:484-487
2. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ: Genetic enhancement of learning and memory in mice. Nature 1999; 401:63-69
3. Meneses A: 5-HT system and cognition. Neurosci Biobehav Rev 2000; 23:1111-1125
4. Buhot MC, Martin S, Segu L: Role of serotonin in memory impairment. Ann Med 2000; 32:210-221
5. Press GA, Amaral DG, Squire LR: Hippocampal abnormalities in amnesic patients revealed by high-resolution magnetic resonance imaging. Nature 1989; 341:54-57
6. Squire LR, Zola-Morgan S: The medial temporal lobe memory system. Science 1991; 253:1380-1386
7. Steckler T, Sahgal A: The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour. Behav Brain Res 1995; 67:165-199
8. Boast C, Bartolomeo AC, Morris H, Moyer JA: 5HT antagonists attenuate MK801-impaired radial arm maze performance in rats. Neurobiol Learn Mem 1999; 71:259-271
9. Meltzer HY: The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999; 21:1065-1155
10. Newman-Tancredi A, Gavaudan S, Conte C, Chaput C, Touzard M, Verriele L, Audinot V, Millan MJ: Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTP-gammaS binding study. Eur J Pharmacol 1998; 355:245-256
11. Elliott J, Reynolds GP: Agonist-stimulated GTPgamma[35S] binding to 5-HT(1A) receptors in human post-mortem brain. Eur J Pharmacol 1999; 386:313-315
12. Meltzer HY, McGurk SR: The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 1999; 25:233-255
13. Velligan DI, Newcomer J, Pultz J, Csernansky J, Hoff AL, Mahurin R, Miller AL: Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res 2002; 53:239-248
14. McGurk SR: The effects of clozapine on cognitive functioning in schizophrenia. J Clin Psychiatry 1999; 60:24-29
15. Sumiyoshi T, Matsui M, Nohara S, Yamashita I, Kurachi M, Sumiyoshi C, Jayathilake K, Meltzer HY: Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment. Am J Psychiatry 2001; 158:1722-1725
16. Sumiyoshi T, Matsui M, Yamashita I, Nohara S, Kurachi M, Uehara T, Sumiyoshi S, Sumiyoshi C, Meltzer HY: The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia. Biol Psychiatry 2001; 49:861-868
17. Farde L, Ito H, Swahn CG, Pike WV, Halldin C: Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. J Nucl Med 1998; 39:1965-1971
18. Pike VW, McCarron JA, Lammertsma AA, Osman S, Hume SP, Sargent PA, Bench CJ, Cliffe IA, Fletcher A, Grasby PM: Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. Eur J Pharmacol 1996; 301:R5-R7
19. Shimizu H, Tatsuno T, Hirose A, Tanaka H, Kumasaka Y, Nakamura M: Characterization of the putative anxiolytic SM-3997 recognition sites in rat brain. Life Sci 1988; 42:2419-2427
20. Shimizu H, Karai N, Hirose A, Tatsuno T, Tanaka H, Kumasaka Y, Nakamura M: Interaction of SM-3997 with serotonin receptors in rat brain. Jpn J Pharmacol 1988; 46:311-314
21. Hamik A, Oksenberg D, Fischette C, Peroutka SJ: Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites. Biol Psychiatry 1990; 28:99-109
22. 1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. J Pharmacol Exp Ther 1993; 264:1364-1376
23. 1A receptor activation and hypothermia: evidence for a postsynaptic mechanism in humans (abstract). Neuropsychopharmacology 1994; 10:92S
24. 1A receptor activation by flesinoxan in humans: body temperature and neuroendocrine responses. Neuropsychopharmacology 1995; 13:93-104
25. Wechsler D: Wechsler Memory Scale - Revised. San Antonio, Tex, Harcourt Brace Jovanovich, 1987
26. Sugishita M: The Japanese Version of the Wechsler Memory Scale - Revised. Tokyo, Nihon Bunka Kagakusya, 2001
27. Yasuno F, Hasnine AH, Suhara T, Ichimiya T, Sudo Y, Inoue M, Takano A, Ou T, Ando T, Toyama H: Template-based method for multiple volumes of interest of human brain PET images. Neuroimage 2002; 16:577-586
28. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C: PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999; 46:1375-1387
29. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, Hume SP, Grasby PM, Lammertsma AA: Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 1998; 8:426-440
30. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ: Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997; 6:279-287
31. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ: Statistical parametric maps in functional imaging: a general linear approach. Human Brain Mapp 1995; 2:189-210
32. Meyer JH, Gunn RN, Myers R, Grasby PM: Assessment of spatial normalization of PET ligand images using ligand-specific templates. Neuroimage 1999; 9:545-553
33. Rey A: L'examen clinique en psychologie. Paris, Presses Universitaires de France, 1964
34. Mitrushina M, Satz P, Chervinsky A, D'Elia L: Performance of four age groups of normal elderly on the Rey Auditory-Verbal Learning Test. J Clin Psychol 1991; 47:351-357
35. Gourovitch ML, Kirkby BS, Goldberg TE, Weinberger DR, Gold JM, Esposito G, Van Horn JD, Berman KF: A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology 2000; 14:353-360
36. Ilan AB, Polich J: Tobacco smoking and event-related brain potentials in a Stroop task. Int J Psychophysiol 2001; 40:109-118
37. Pruessner JC, Collins DL, Pruessner M, Evans AC: Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood. J Neurosci 2001; 21:194-200
38. Maeda J, Suhara T, Ogawa M, Okauchi T, Kawabe K, Zhang MR, Semba J, Suzuki K: In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin. Synapse 2001; 40:122-129
39. Carli M, Tatarczynska E, Cervo L, Samanin R: Stimulation of hippocampal 5-HT1A receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat. Eur J Pharmacol 1993; 234:215-221
40. Kant GJ, Meininger GR, Maughan KR, Wright WL, Robinson TN III, Neely TM: Effects of the serotonin receptor agonists 8-OH-DPAT and TFMPP on learning as assessed using a novel water maze. Pharmacol Biochem Behav 1996; 53:385-390
41. Pugliese AM, Passani MB, Corradetti R: Effect of the selective 5-HT1A receptor antagonist WAY 100635 on the inhibition of epsps produced by 5-HT in the CA1 region of rat hippocampal slices. Br J Pharmacol 1998; 124:93-100
42. Carli M, Bonalumi P, Samanin R: WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Res 1997; 774:167-174
43. Harder JA, Ridley RM: The 5-HT1A antagonist, WAY 100635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys. Neuropharmacology 2000; 39:547-552
44. Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M: Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin (1A) receptors. Proc Natl Acad Sci USA 2000; 97:14731-14736
45. Millan MJ, Lejeune F, Gobert A: Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J Psychopharmacol 2000; 14:114-138
46. Whitaker-Azmitia PM: Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev 1991; 43:553-561
47. 1A agonists. Mol Pharmacol 1990; 37:231-237
48. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C: Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann NY Acad Sci 1998; 861:204-216
49. Millan MJ: Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. J Pharmacol Exp Ther 2000; 295:853-861